FindTrial
Sign In

Role of Rauvolfia serpentina mother tincture in Hypertention

Phytochemical standardization and clinical verification of Rauvolfia serpentina mother tincture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024231
Enrollment
60
Registered
2020-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I00-I99- Diseases of the circulatory system

Interventions

Intervention1: Rauvolfia serpentina mother tincture from wild and cultivatd species: 10 drops with cup of water orally for twice a daily for seven days Control Intervention1: Anti hypertensive allopat

Sponsors

Dr Varsha Ghate
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with mild essential hypertension who are willing to participate and give informed conscent

Exclusion criteria

Exclusion criteria: secondary hypertension, pregnancy, lactation, allergic to reserpine

Design outcomes

Primary

MeasureTime frame
Reduction in systolic and diastolic blood pressureTimepoint: After seven to fifteen days—

Secondary

MeasureTime frame
other standardization parameters of mother tinctureTimepoint: one month—

Countries

India

Contacts

Public Contactvarsha ghate

Bharti vidhyapeeth Homoeopathic medical college and hospital, pune

drgajendragadkarm@gmail.com07276862885

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026